Skip to main content
. 2010 May 19;37(6):1281–1294. doi: 10.1093/schbul/sbq046

Table 1.

Participant Characteristics

Schizophrenia Relative Control
N 27 23 36
Age 43.4 (10.1)a 49.8 (6.5) 42.1 (11.4)a
Gender (% female) 22a 65 44
Education (years completed) 14.3 (2.5)b 14.5 (2) 15.5 (1.9)
Education (% HS completed) 93 100 97
Maternal education (% HS completed) 82 87 89
Intelligence quotient 99.5 (12.6)a,b 109.9 (17.4) 108.2 (13.2)
Handedness (% right handed) 96 87 86
BPRS total: range 46 (13): 27–74 29 (4): 24–38c 28 (4): 24–45c
SANS total: range 26 (15): 2–47
SAPS total: range 18 (16): 1–55
Years ill: range 21 (11): 1–37
CPZ equivalence 523 (558)
Axis I (% with any lifetime diagnosis) 52d 39e
Relative status—Parent:sibling 3:20

Note: Data was missing from 1 patient, 2 relatives, and 2 controls for the face recognition tasks. HS, high school; estimated intelligence quotient was measured using Wechsler Adult Intelligence Scale-Third Edition Vocabulary and Block Design subtests.55 BPRS, Brief Psychiatric Rating Scale: 24 items, scores can range from 24 to 168; SANS, Scale for Assessment of Negative Symptoms: 20 items, scores can range from 0 to 100; SAPS, Scale for Assessment of Positive Symptoms: 30 items, scores can range from 0 to 150. CPZ, chlorpromazine equivalence for antipsychotic medications.

a

Less than relatives.

b

Less than controls.

c

Less than patients.

d

Relatives had a lifetime history of the following Axis I disorders (some relatives has more than one disorder): depressive disorder (5 participants), posttraumatic stress disorder (1 participant), cocaine dependence (1 participant), alcohol abuse (8 participants), cannabis abuse (1 participant), and stimulant abuse (1 participant).

e

Controls had a lifetime history of the following Axis I (some controls has more than one disorder): depressive disorder (5 participants), anxiety disorder (6 participants), bulimia (1 participant), attention-deficit hyperactivity disorder (1 participant), cocaine dependence (1 participant), alcohol dependence (6 participants), alcohol abuse (5 participants), cannabis abuse (2 participants), and stimulant abuse (1 participant).